These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36734285)

  • 1. Lack of association between vitiligo and major adverse cardiovascular events: A population-based cohort study.
    Wu PC; Ma SH; Wu CY; Pan TY; Chang YT; Wu CY
    J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):e773-e775. PubMed ID: 36734285
    [No Abstract]   [Full Text] [Related]  

  • 2. Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study.
    Canu D; Shourick J; Andreu N; Gey A; Ballanger-Désolneux F; Barailler H; Boniface K; Ezzedine K; Seneschal J
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e676-e679. PubMed ID: 34013570
    [No Abstract]   [Full Text] [Related]  

  • 3. The Incidence, Prevalence, and Mortality of Vitiligo in Korea: A Nationwide Population-Based Cohort Study.
    Lee YB; Kim S; Kim HS
    J Cutan Med Surg; 2023; 27(2):166-167. PubMed ID: 36579730
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors associated with perceived stress in patients with vitiligo in the ComPaRe e-cohort.
    Condamina M; Shourick J; Seneschal J; Sbidian E; Andreu N; Pane I; Ravaud P; Tran VT; Ezzedine K
    J Am Acad Dermatol; 2022 Mar; 86(3):696-698. PubMed ID: 33684495
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitiligo and systemic sclerosis: Are they associated?- Lessons from a population-based study.
    Kridin K; Lyakhovitsky K; Tzur-Bitan D; Onn E; Lyakhovitsky A; Zoller L; Cohen AD
    Australas J Dermatol; 2023 Feb; 64(1):e65-e71. PubMed ID: 36326157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of childhood-onset vitiligo and increased risk of atopic dermatitis, autoimmune diseases, and psoriasis: A nationwide population-based study.
    Lim JH; Lew BL; Sim WY; Kwon SH
    J Am Acad Dermatol; 2022 Nov; 87(5):1196-1198. PubMed ID: 35276286
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of COVID-19 related complications in vitiligo patients: A database study.
    Raiker R; Pakhchanian H; Salingaros S; Helm M
    J Dtsch Dermatol Ges; 2022 Nov; 20(11):1505-1508. PubMed ID: 36210055
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous vitiligo associated with choroidal hypopigmentation.
    Vingerling JR; Owens S; van der Meijden WI; Hoyng CB; Bird AC
    Eye (Lond); 2004 Sep; 18(9):939-40. PubMed ID: 15002019
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitiligo adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021.
    Learned C; Cohen SR; Alsukait S; Deverapalli S; Rosmarin D
    J Am Acad Dermatol; 2023 Jan; 88(1):197-199. PubMed ID: 35427685
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical Pattern of Choroidal Hypopigmentation with Cutaneous Vitiligo.
    Kim M; Kwon JW; Park YH
    Korean J Ophthalmol; 2019 Feb; 33(1):99-100. PubMed ID: 30746919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Increased depigmentation in vitiligo after roentgen irradiation].
    SCHMITT HG
    Strahlentherapie; 1955 May; 97(1):159-60. PubMed ID: 13246889
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining the psychological comorbidity in vitiligo: systematically casting the net wide.
    Thomson J
    Br J Dermatol; 2018 Apr; 178(4):826. PubMed ID: 29668098
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiotherapy-induced vitiligo: A systematic review of patient demographics and clinical characteristics of vitiligo following radiation therapy.
    Mansour MR; Abushukur Y; Rehman RA; Shah C; Mehregan D
    J Am Acad Dermatol; 2022 Dec; 87(6):1445-1448. PubMed ID: 35995610
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitiligo in underrepresented communities: An All of Us database analysis.
    Ahmed F; Moseley I; Ragi SD; Ouellette S; Rao B
    J Am Acad Dermatol; 2023 Apr; 88(4):945-948. PubMed ID: 36414097
    [No Abstract]   [Full Text] [Related]  

  • 15. Segmental vitiligo-like hypopigmentation associated with metastatic melanoma.
    Cerci FB; Mesquita LA; Silva de Castro CC
    Cutis; 2017 Jun; 99(6):E1-E2. PubMed ID: 28686764
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with vitiligo present fewer cardiovascular risk factors: results from a case-control study.
    Rodríguez-Martín M; de Paz NM; Mehtani P; Ferrer PC; Eliche MP; Martín BR; Sáez M; García M; Noda A
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):124-5. PubMed ID: 22176574
    [No Abstract]   [Full Text] [Related]  

  • 17. Nail abnormalities in patients with vitiligo.
    Topal IO; Gungor S; Kocaturk OE; Duman H; Durmuscan M
    An Bras Dermatol; 2016; 91(4):442-5. PubMed ID: 27579738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side lighting to enhance the visualization of leukotrichia in vitiligo.
    AlJasser MI
    J Am Acad Dermatol; 2022 Aug; 87(2):e59. PubMed ID: 35259453
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitiligo Iridis in a Patient With a History of Smallpox.
    Mahendradas P; Nahata H; Acharya I
    JAMA Ophthalmol; 2022 Dec; 140(12):e224444. PubMed ID: 36520157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of rs4711998 of IL-17A, rs2275913 of IL-17A and rs763780 IL-17F gene polymorphisms with non-segmental vitiligo in a Mexican population.
    Zapata-Salazar NA; Kubelis-Lopez DE; Salinas-Santander MA; Sanchez-Dominguez CN; Xolalpa-Rosales AC; Gomez-Galindo ME; Ocampo-Candiani J
    Arch Dermatol Res; 2023 Apr; 315(3):447-454. PubMed ID: 35960353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.